Cannabis Law Report

JUNE 16, 2021

If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain. This hot new cannabinoid has been branded as “legal marijuana” as the main intoxicating compound in cannabis but one most commonly derived from hemp for commercial use.

THC 117

THC Hemp Media Data 117

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.

Media 52

Media CBD Events THC 52

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. CHARLOTTE, N.C.–(BUSINESS

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? The cannabis research problem. Types of Research.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

JANUARY 6, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announced today that it has appointed Scott L. AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Customers’ only way to know the levels of cannabinoids and other ingredients these products contain is by reviewing labels, marketing claims, and checking certificates of analysis.

THC 52

THC CBD Media Food 52

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). For example, rather than having researchers carry out a controlled investigation, each study subject provided self-reported data.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

Cannabis Law Report

NOVEMBER 22, 2019

. “MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking.” For media inquiries please contact: Michael Sharp. For more information visit: [link]. 561-627-9455. For Investment Opportunities: MFS Capital Advisors.

DEA 66

DEA Clinical Trials THC Research and Development 66

Medicinal Genomics

FEBRUARY 20, 2019

Recently, Oregon CBD made a statement on its social media accounts, calling for the end of male hemp cultivation outdoors in Oregon and other areas that are currently devoid of feral hemp populations. Industrial hemp is often harvested for its nutritious seeds or fibrous stalk, not its cannabinoid and terpene-rich flower.

Hemp 100

Hemp Cultivation Cannabinoids CBD 100

Cannabis Law Report

JUNE 3, 2021

Study To Explore Effects of cbdMD’s Proprietary Cannabinoid Blend On Pets Who Suffer From Osteoarthritis. The results from this study will provide validating data on the efficacy of the Company’s products in reducing pain and improving joint mobility in dogs. CHARLOTTE, N.C.–(BUSINESS About cbdMD, Inc. cbdMD, Inc.

Programs 83

Programs Pets Tincture CBD 83

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Forward-looking statements.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

CannaMD

MAY 19, 2020

As the study authors acknowledge: Cannabis sativa, especially one high in the anti-inflammatory cannabinoid cannabidiol (CBD), has been proposed to modulate gene expression and inflammation and is under investigation for several potential therapeutic applications against cancer and various inflammatory diseases. Why Study Marijuana?

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

CannaMD

NOVEMBER 6, 2019

Perhaps the commercialization of marijuana and the favorable media coverage surrounding the health effects of marijuana are fostering such a perception. Some of the more interesting data on the relationship between opioids and medical marijuana for pain management comes from the field of orthopedic surgery. million to 11.4

Marijuana 87

Marijuana Patients Clinical Trials Data 87

SpeedWeed

MARCH 7, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss international licenses in Columbia and Canada as well as new point-of-sale and CRM data being added to the Cannabiz Media License Database. We’re your hosts, Amanda Guerrero and Ed Keating.

Extraction 52

Extraction Hemp Data Media 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. Muscle pain, joint pain and pain within the nervous system are all shown to be reduced through the use of anti-inflammatory medication, and cannabinoids are anti-inflammatory. Final comments.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor. Throughout the 20th century, the “stoner” stereotype was often portrayed in the media. Emerald Group Publishing Limited. Moscowitz, L.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

JULY 13, 2022

Proposed the first state validated test method for cannabinoids to support laboratory compliance and ensure integrity in cannabis products. Responded to more than 200 media inquiries, providing accurate and compelling information to the public about our work and impact. the eradication of 1.25 million cannabis plants.

Compliance 52

Compliance Compliance Supply Chain Environment 52

Cannabis Law Report

DECEMBER 14, 2021

There are 28 million people suffering from chronic pain in the UK and this range of formulations offers pain doctors the best and most comprehensive selection of cannabinoid treatment options for their patients. We are proud to leverage our proprietary IP, formulation expertise, safety surveillance and patient reported data from the U.S.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

DECEMBER 6, 2021

We look forward to Jeff’s significant contributions heading into another year of continued growth and progress for Goldfinch Bio, including a planned interim data readout from TRACTION-2, the ongoing Phase 2 clinical trial of our lead precision kidney medicine candidate, in mid-2022.”. Media: Liz Melone. Stern Investor Relations, Inc.

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

Weedistry

JANUARY 28, 2019

Cannabinoid-derived product by Ontario-based Tetra Bio-Pharma to be officially recognized as a drug. The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. Something needs to be done”: Making medicine attainable and affordable.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

CannaMD

AUGUST 19, 2020

Marijuana cannabinoid, CBD. While future research is needed, the present study opens up a new landscape for marijuana research – focusing on terpenes just as much as cannabinoids. Our initial data suggest that some C. Note: Study extracts were applied via media. ” And their alternative strategy of choice?

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

The Joint Blog

JULY 25, 2020

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. In the same report, the agency wrote: “Of the 31 products tested for cannabinoids, 21 products specified the amount of CBD in the product (e.g., CBD is everywhere these days. CBD amount per serving).

CBD 33

CBD Clinical Trials Safety Media 33

Cannabis Law Report

SEPTEMBER 24, 2019

Cannabidiol oral solution contains highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the “high” associated with cannabis. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with LGS and Dravet syndrome. All investor and media enquiries.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

OCTOBER 14, 2021

1 Source: Headset data for tracked US states. 2 Source: Wana data and internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and Canopy Growth’s retail store operations across the country, 13W ended 9/13/21. About Canopy Growth.

Edibles 52

Edibles Data Marijuana Events 52

Veriheal

DECEMBER 11, 2020

The EU Court stated, “The national court must assess available scientific data to make sure that the real risk to public health alleged does not appear to be based on purely hypothetical considerations. According to French law, only seeds and the fiber from hemp that has less than 0.2% THC is allowed to be utilized commercially.

CBD 52

CBD Topical Pharmaceutical Hemp 52

Medicinal Genomics

SEPTEMBER 27, 2018

Within this blog post, we have identified the statements included in the Analytical Cannabis article that Medicinal Genomics knows to be false, those that are true, as well as supplemental data on our position on each specific issue. This is an assumption that works well in short-form media but fails under any prolonged scientific scrutiny.

Food 69

Food Data Safety Patients 69

StrainConnect

MARCH 9, 2019

Before we jump in, you’re about to hear a lot of the term “cannabinoid.” ” Let’s recreate our school days with a little vocabulary lesson to help curb any confusion: Cannabinoids : the compounds that are found explicitly within the Cannabis sativa L. Why Cannabinoids Act as Therapeutic Agents.

Research and Development 42

Research and Development Cannabinoids Sativa THC 42

Cannabis Law Report

NOVEMBER 2, 2021

Delta-8 THC is making big waves in the cannabis industry at the minute, but with warnings from the FDA and CDC , not to mention harrowing accounts from users , it’s clear there’s more going on with the novel cannabinoid than meets the eye. Those cannabinoids are easier to extract so there’s less risk with doing it wrong.

THC 96

THC CBD Legalization Vaping 96

SpeedWeed

MAY 25, 2021

Wurzer agreed, saying “I don’t have a ton of good data on this.”. While studies varied widely, “there may be some support for the claim that hemp wick results in less loss of cannabinoids and terpenoids during combustion,” Lewis said. Hippie wick health. Burning anything organic gives off carcinogens, he said. Is it snack time yet?

Hemp 52

Hemp Vaping Hash Tincture 52

Cannabis Law Report

OCTOBER 29, 2021

We expect to report this data as it becomes available and after submission to the FDA. social media: www.igcinc.us / www.igcpharma.com. in thousands, except share data). . . . in thousands, except loss per share and share data). . . Net loss for the three months ended September 30, 2021, was approximately $4.3

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

JANUARY 27, 2020

9-tetrahydrocannabinol (THC), the psychoactive component in hemp, that occurs only at very low levels (below 0.3%) in most hemp grown as a source of its non-psychoactive cannabinoid relative, CBD. It appeared comprehensive and relied on data mainly from food authorities but also from industry. Alarm 2: EFSA, EU.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

FEBRUARY 17, 2022

The Commission requires all licensees to test Marijuana and Marijuana Products for their cannabinoid profile and contaminants of concern. All Marijuana and Marijuana Products must be tested for their Cannabinoid Profile and certain contaminants of concern, as specified by the Commission. 94G, § 15(a)(2). 935 Code Mass.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

JULY 23, 2019

After using Koi’s products, Thurston was given a random drug test by her employer, which came back positive for cannabinoids. She lost her job as a result. Some states require mandatory warning statements in advertisements for medical cannabis. a playground, recreation centre, library or public park.

Law 40

Law Clinical Trials CBD Edibles 40